Neurogene's market cap is currently ―. The company's EPS TTM is $-2.654; its P/E ratio is -12.70; Neurogene is scheduled to report earnings on May 10, 2024, and the estimated EPS forecast is $-1.03. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	-	-	-	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -3.07M	$ -15.13M	$ -14.25M	$ -13.61M	$ -15.87M
EBITDA	-	$ -15.05M	$ -14.00M	$ -13.02M	$ -15.15M
Net Income Common Stockholders	$ -2.08M	$ -14.20M	$ -13.45M	$ -13.07M	$ -15.69M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 82.06M	$ 83.44M	$ 96.38M	$ 106.88M	$ 116.46M
Total Assets	$ 94.00M	$ 98.46M	$ 115.95M	$ 126.58M	$ 137.02M
Total Debt	$ 11.04M	$ 11.68M	$ 12.07M	$ 12.07M	$ 12.43M
Net Debt	$ -71.02M	$ -71.75M	$ -84.31M	$ -94.81M	$ -104.03M
Total Liabilities	$ 14.43M	$ 17.10M	$ 21.62M	$ 20.93M	$ 20.31M
Stockholders Equity	$ 79.58M	$ 81.36M	$ 94.33M	$ 105.65M	$ 116.71M
Cash Flow	-
Free Cash Flow	-	$ -13.47M	$ -11.04M	$ -9.61M	$ -11.53M
Operating Cash Flow	$ -4.05M	$ -13.05M	$ -10.93M	$ -9.29M	$ -11.29M
Investing Cash Flow	$ -411.00K	$ 10.71M	$ 8.47M	$ -27.85M	$ -39.30M
Financing Cash Flow	$ -294.00K	$ -66.00K	$ 18.00K	$ -52.00K	$ 62.00K

Currency in USD

Neurogene Earnings and Revenue History

Income Statement >

Neurogene Debt to Assets

Balance Sheet >

Neurogene Cash Flow

Cash Flow >

Neurogene Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing